Printer Friendly

United States : Potential of induced pluripotent stem cells used for generating medicine for in vivo modelling.

A new way of changing induced pluripotent stem cells (iPSCs) into hematopoietic control and progenitor cells for in vivo modeling has been reported by a panel led by investigators in the Boston Children's Hospital's Stem Cell Transplantation Program.

With this strategy-which they call re-specification-the team, such as Sergei Doulatov, PhD, and Gretchen Daley, MD, PhD, of Boston Children's, may have got over particular restrictions to generating veins disease-specific animal models from a huge number of iPSC cell lines now sitting in lab freezers all over the globe.

The main benefits of the method can be found in the raw content. The study team started with iPSCs that had by now been aimed at becoming myeloid progenitors, which are more properly relevant to the recommended veins progenitors than skin or other completely categorized cell types normally used stem cell assessments.

The investigators then used a choose set of interpretation aspects to turn back the molecular time just a little on these devoted myeloid cells, changing them into veins progenitors that easily engrafted and categorized when replanted into mice.

The re-specification method could assist produce lots of engraftable cells required to make animal models from iPSCs created from human patients having difficulties of blood disorders, such as anemias, thalassemia or sickle cell disease.

2013 Al Bawaba (Albawaba.com)

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2013 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:Oct 7, 2013
Words:224
Previous Article:United States : SYNTHETIC Metabolic path identified as substitute for GLYCOLYSIS at UCLA.
Next Article:Uzbekistan : ADB sanctions $220 million loan for modernization of irrigation infrastructure in BUKHARA.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters